Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia

Neurology

Volumn 85, Issue 10, 2015, Pages 898-904

  Rajan, Kumar B ^a   Wilson, Robert S ^b,c   Weuve, Jennifer ^a   Barnes, Lisa L ^b,c   Evans, Denis A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL EVALUATION; COGNITION ASSESSMENT; COGNITIVE DEFECT; EPISODIC MEMORY; EUROPEAN AMERICAN; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; BRIEF PSYCHIATRIC RATING SCALE; CAUCASIAN; COGNITION DISORDERS; ETHNOLOGY; HEALTH SURVEY; ILLINOIS; LONGITUDINAL STUDY; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; TIME FACTOR; VERY ELDERLY;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRIEF PSYCHIATRIC RATING SCALE; CHICAGO; COGNITION DISORDERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84944529208     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001774     Document Type: Article

References (39)

1. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part I: clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
2. Troncoso JC, Cataldo AM, Nixon RA, et al. Neuropathol-ogy of preclinical and clinical late-onset Alzheimer's disease. Ann Neurol 1998;43:673-676.
3. Jack CR Jr, Knopman DS, Weigand SD, et al. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol 2012;71:765-775.
4. Hampel H. Current insights into the pathophysiology of Alzheimer's disease: selecting targets for early therapeutic intervention. Int Psychogeriatr 2012;suppl 1:S10-S17.
5. Burns JM, Klunk WE. Predicting positivity for a new era of Alzheimer disease prevention trials. Neurology 2012;79: 1530-1531.
6. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-128.
7. Jack CR Jr, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013;12:207-216.
8. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82: 239-259.
9. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794.
10. Braak H, Braak E. Development of Alzheimer-related neu-rofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 1996;92:197-201.
11. Braak E, Arai K, Braak H. Cerebellar involvement in Pick's disease: affliction of mossy fibers, monodendritic brush cells, and dentate projection neurons. Exp Neurol 1999;159:153-163.
12. Jack CR Jr, Petersen RC, Xu Y, et al. Rates of hippocam-pal atrophy correlate with change in clinical status in aging and AD. Neurology 2000;55:484-489.
13. Aretouli E, Tsilidis KK, Brandt J. Four-year outcome of mild cognitive impairment: the contribution of executive dysfunction. Neuropsychology 2013;27:95-106.
14. Schneider AL, Gottesman RF, Mosley T, et al. Cognition and incident dementia hospitalization: results from the Atherosclerosis Risk in Communities Study. Neuroepi-demiology 2013;40:117-124.
15. Twamley EW, Ropacki SA, Bondi MW. Neuropsycholog-ical and neuroimaging changes in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2006;12:707-735.
16. Cervilla J, Prince M, Joels S, Lovestone S, Mann A. Pre-morbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype. J Neurol Neurosurg Psychiatry 2004;75: 1100-1106.
17. Hall CB, Lipton RB, Sliwinski M, Stewart WF. A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med 2000;19: 1555-1566.
18. Wolf PA. Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years. Arch Neurol 2012;69:567-571.
19. Amieva H, Jacqmin-Gadda H, Orgogozo JM, et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 2005; 128:1093-1101.
20. Johnson DK, Storandt M, Morris JC, Galvin JE. Longitudinal study of the transition from healthy aging to Alzheimer disease. Arch Neurol 2009;66:1254-1259.
21. Small BJ, Bäckman L. Longitudinal trajectories of cognitive change in preclinical Alzheimer's disease: a growth mixture modeling analysis. Cortex 2007;43:826-834.
22. Grober E, Hall CB, Lipton RB, Zonderman AB, Resnick SM, Kawas C. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2008;14: 266-278.
23. Howieson DB, Carlson NE, Moore MM, et al. Trajectory of mild cognitive impairment onset. J Int Neuropsychol Soc 2008;14:192-198.
24. Wilson RS, Leurgans SE, Boyle PA, Bennett DA. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol 2004;68:351-356.
25. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort. Arch Neurol 2000;57:808-813.
26. Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol 2008;64:492-498.
27. Bienias JL, Beckett LA, Bennett DA, Wilson RS, Evans DA. Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis 2003;5:349-355.
28. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a biracial urban community. Arch Neurol 2003;60:185-189.
29. Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-178.
30. Wilson RS, Bennette DA, Bienias JL, et al. Cognitive activity and incident AD in a population-based sample of older persons. Neurology 2002;59:1910-1914.
31. Smith A. Symbol Digits Modalities Test. Los Angeles: Western Psychological Services; 1982.
32. Folstein MF, Folstein SE, McHugh TR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
33. Wilson RS, Benette DA, Beckett LA, et al. Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci 1999;54: 155-160.
34. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34: 939-944.
35. Manly JJ, Jacobs DM, Touradji P, et al. Reading level attenuates differences in neuropsychological test performance between African American and white elders. J Int Neuropsychol Soc 2002;8:341-348.
36. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989.
37. SAS Institute Inc. SAS 9.3 Help and Documentation. Cary, NC: SAS Institute Inc.; 2011.
38. Kawas CH, Corrada MM, Brookmeyer R, et al. Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology 2003;60:1089-1093.
39. Bateman RJ, Xiong C, Benzinger TLS, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367:795-804.